Medical device manufacturing operates under significant constraints. Every process change, supplier modification, or facility decision is tied to regulatory obligation. The operational consequences of a mistake extend from production downtime to a product recall. In 2024, the industry recorded 1,059 recall events, a four-year high, with Class I recalls - the most serious category - reaching a 15-year peak. The industry faces up to $5 billion in annual costs from recalls alone, with a single event capable of costing a manufacturer up to $600 million (before potential litigation).
Your Chief Operating Officer and Manufacturing Director are not running efficiency lines - they are sustaining the quality infrastructure that underpins market authorization, while driving cost performance and scaling capacity ahead of commercial demand. In this environment, there is no low-stakes appointment.